To bring excellence and experience in technical/scientific/medical/clinical pharmacology and early development to the biotechnology/pharmaceutical/CRO and health organizations.I have extensive practical experience consulting in therapeutic areas involving diseases in patients with Cancer, Cardio-Pulmonary, Metabolic, Neurological, Renal, Rheumatological and Infectious diseases with a special interest involving immunological biomarker pathway assessments. I have developed and written protocols, reviewed, analyzed and written Clinical Summary Reports involving PK/PD and Safety data as well as providing drug development insight, advice and recommendations to Sponsor’s clinical developmental plans. In addition, I am a reviewer for Western–Copernicus Group’s division for Ethical and Biosafety Review. I have also reviewed and rendered opinions on medical malpractice cases, involving drug-drug interactions and testified in court, as an Expert Witness in the fields of Internal and Emergency Medicine and Clinical Pharmacology.I have been medical director and principal investigator involved in business development, developing clinical trial budgets, writing clinical protocols and trial summaries. Conducted over 300 phase I, II and III, clinical trials that included First-In-Human SAD, MAD, Food Effect, Drug-Drug Interaction Studies. Also, conducted over 40 Special Patient population studies in patients with respiratory (COPD, asthma), hepatic and renal diseases. In addition, evaluating numerous immune modulating drugs employing the endotoxin challenge model in over 1900 healthy volunteers.As a trained physician in internal & emergency medicine and in basic & clinical pharmacology with experience in all phases of the drug development process, I have consulted for the pharmaceutical & biotech industries as well as reviewing legal cases; serving as an expert witness as a board certified, clinical pharmacologist.